Literature DB >> 7744229

Regulation of aldose reductase gene expression in renal cortex and medulla of rats.

R I Dorin1, V O Shah, D L Kaplan, B S Vela, P G Zager.   

Abstract

A role for aldose reductase-mediated production of polyol in the aetiology of diabetic nephropathy has been supported by both animal and clinical studies. In the renal medulla, the rate of polyol production is influenced in part by regulated changes in the level of aldose reductase gene expression. However, little is known about the expression of aldose reductase in the renal cortex. In this study, we evaluated the regulation of aldose reductase gene expression in the renal cortex and medulla in response to galactose feeding. Four groups of rats (n = 6) were treated for 9 weeks with control or galactose diet in the presence or absence of sorbinil, an aldose reductase inhibitor. In the renal medulla, galactose treatment produced a significant (p < 0.01) decrease in aldose reductase mRNA, to approximately 10% of control levels. Coadministration of sorbinil partially prevented the effect of galactose feeding on medullary aldose reductase mRNA (to 43% of control). Under basal conditions, the concentration of aldose reductase mRNA in the cortex was only 1% that of the renal medulla. Galactose feeding significantly reduced cortical aldose reductase mRNA by 29% relative to control (p < 0.01), and this was completely reversed by addition of sorbinil. Sorbinil administration to rats fed a control diet also decreased aldose reductase expression in the renal medulla and cortex. These results demonstrate that galactose feeding results in dynamic, polyol-dependent regulation of aldose reductase gene expression in the renal cortex as well as the medulla.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744229     DOI: 10.1007/BF02369352

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

1.  Effects of osmotic stress and hyperglycemia on aldose reductase gene expression in human renal proximal tubule cells.

Authors:  J M Petrash; M Flath; D Sens; J Bylander
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

2.  Purified rat lens aldose reductase. Polyol production in vitro and its inhibition by aldose reductase inhibitors.

Authors:  P F Kador; J H Kinoshita; D R Brittain; D J Mirrlees; C M Sennitt; D Stribling
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

3.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

4.  Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA.

Authors:  K Tokunaga; H Taniguchi; K Yoda; M Shimizu; S Sakiyama
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

Review 5.  The sorbitol pathway and the complications of diabetes.

Authors:  K H Gabbay
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

Review 6.  Epidemiologic approach to the etiology of type I diabetes mellitus and its complications.

Authors:  A S Krolewski; J H Warram; L I Rand; C R Kahn
Journal:  N Engl J Med       Date:  1987-11-26       Impact factor: 91.245

7.  Aldose reductase from human skeletal and heart muscle. Interconvertible forms related by thiol-disulfide exchange.

Authors:  D L Vander Jagt; B Robinson; K K Taylor; L A Hunsaker
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

8.  Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat.

Authors:  A Das; R N Frank; N L Zhang
Journal:  Diabetologia       Date:  1990-09       Impact factor: 10.122

9.  Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.

Authors:  A Beyer-Mears; L Ku; M P Cohen
Journal:  Diabetes       Date:  1984-06       Impact factor: 9.461

10.  Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition.

Authors:  M M Pedersen; J S Christiansen; C E Mogensen
Journal:  Diabetes       Date:  1991-05       Impact factor: 9.461

View more
  4 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Glucose-specific regulation of aldose reductase in capan-1 human pancreatic duct cells In vitro.

Authors:  J V Busik; S R Hootman; C A Greenidge; D N Henry
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis.

Authors:  R P Eaton; C Qualls; J Bicknell; W L Sibbitt; M K King; R H Griffey
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Effect of an aldose reductase inhibitor on type IV collagen production by human endothelial cells cultured in high glucose.

Authors:  A Bakillah; A M Grigorova-Borsos; R Guillot; P Urios; M Sternberg
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.